Spring Bank Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Milford MA United States (2002)
Status: Acquired by F-star Delta Limited (2020)

Organization Overview

First Clinical Trial
2013
NCT01803308
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Spring Bank Pharmaceuticals | Spring Bank Pharmaceuticals, Inc.